IAP0971 not checked
SUNHO(China)BioPharmaceutical CO., Ltd.
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Induction period (6 weeks): IAP0971 combined with BCG,Bladder perfusion, once a week;Maintenance period: IAP0971 combined with BCG bladder irrigationNote, progress at months 3, 6, 12, 18, and 24Perform maintenance perfusion once a week, three times in a row.”In the company’s words, NCT06255964 on ClinicalTrials.gov
- Tested for
- Bladder Cancer, Advanced Malignant Tumors, Advanced Malignant Neoplasm, Advanced or Metastatic Non-small Cell Lung Cancer
- Main trialPhase 1/2
- “The efficacy and safety of IAP0971 single drug or combined with BCG intravesical instillation in the treatment of high-risk non muscle invasive bladder cancer with BCG treatment failure.”In the company’s words, NCT06255964 on ClinicalTrials.gov
Other drugs for Bladder Cancer
- Cretostimogene GrenadenorepvecCG Oncology, Inc. · Phase 3
- Nogapendekin alfa inbakiceptImmunityBio · Phase 2/3
- Disitamab vedotinPfizer · Phase 3
- PembrolizumabMerck & Co. · Phase 3
- CetrelimabJohnson & Johnson (Janssen) · Phase 3
- TAR-200Johnson & Johnson (Janssen) · Phase 3
Coming up1
- 1 Aug 2029Phase 1/2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Not yet recruiting | 7 Oct 2024 | A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer | |
| Phase 1/2Recruiting | 1 Mar 2026 | A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors | |
| Phase 1/2Recruiting | 1 Aug 2029 | A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors | |
| Phase 1/2Unknown | 30 May 2024 | A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026